0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Cardiovascular medicine

Buy Now

Cardiac Safety of Noncardiac Drugs - Practical Guidelines for Clinical Research and Drug Development (Hardcover, 2005 ed.) Loot Price: R4,405
Discovery Miles 44 050
Cardiac Safety of Noncardiac Drugs - Practical Guidelines for Clinical Research and Drug Development (Hardcover, 2005 ed.):...

Cardiac Safety of Noncardiac Drugs - Practical Guidelines for Clinical Research and Drug Development (Hardcover, 2005 ed.)

Joel Morganroth, Ihor Gussak

 (sign in to rate)
Loot Price R4,405 Discovery Miles 44 050 | Repayment Terms: R413 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

It is generally easy to define the efficacy of a new the- peutic agent. However, what is even more difficult and more challenging yet more important is to define its safety when administered to millions of patients with multi-faceted d- eases, co-morbidities, sensitivities and concomitant medi- tions. The commonest cause of new drug discontinuations, cause for disapproval from marketing and removal from the market after approval is a drug's effect on cardiac repolari- tion which is essentially identified by increasing the duration of the QTc interval duration on the standard 12-lead elect- cardiogram (ECG). Cardiac Safety of Noncardiac Drugs: Practical Guide- Joel Morganroth, MD lines for Clinical Research and Drug Development is designed to present the current preclinical, clinical, and re- latory principles to assess the cardiac safety of new drugs based primarily on their effects on the ECG. Practical gu- ance to define cardiac safety at all stages of clinical research and drug development are featured and discussed by inter- tionally recognized experts with academic, industrial, and regulatory experience. Each chapter contains the best ava- able evidence, the author's personal opinions, areas of c- troversy, and future trends. Although some of the areas are highly specialized, this book has been designed for a broad audience ranging from medical and graduate students to cli- cal nurses, clinical trial coordinators, safety officers, data managers, statisticians, regulatory authorities, clinicians, and Ihor Gussak, MD, PhD scientists.

General

Imprint: HumanaPress
Country of origin: United States
Release date: November 2004
First published: 2005
Editors: Joel Morganroth • Ihor Gussak
Dimensions: 254 x 178 x 26mm (L x W x T)
Format: Hardcover
Pages: 362
Edition: 2005 ed.
ISBN-13: 978-1-58829-515-6
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
Books > Medicine > Other branches of medicine > Pharmacology > General
Promotions
LSN: 1-58829-515-X
Barcode: 9781588295156

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners